ReviewBiophysical reviews2017

The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.

Prashant Deshmukh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.